BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17700277)

  • 1. Contrast-enhanced magnetic resonance angiography: P792 blood pool agent versus Gd-DOTA in rabbits at 3.0 T versus 1.5 T.
    Herborn CU; Watkins DM; Baumann S; Robert P; Corot C; Runge VM
    Invest Radiol; 2007 Sep; 42(9):622-8. PubMed ID: 17700277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR angiography with a new rapid-clearance blood pool agent: Initial experience in rabbits.
    Ruehm SG; Christina H; Violas X; Corot C; Debatin JF
    Magn Reson Med; 2002 Nov; 48(5):844-51. PubMed ID: 12417999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced magnetic resonance angiography: evaluation of the high relaxivity low diffusible gadolinium-based contrast agent P846 in comparison with gadoterate meglumine in rabbits at 1.5 Tesla and 3.0 Tesla.
    Peldschus K; Hamdorf M; Robert P; Port M; Graessner J; Adam G; Herborn CU
    Invest Radiol; 2008 Dec; 43(12):837-42. PubMed ID: 19002055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced magnetic resonance angiography in rabbits: evaluation of the gadolinium-based agent p846 and the iron-based blood pool agent p904 in comparison with gadoterate meglumine.
    Kinner S; Maderwald S; Parohl N; Albert J; Corot C; Robert P; Barkhausen J; Vogt FM
    Invest Radiol; 2011 Aug; 46(8):524-9. PubMed ID: 21577130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR diagnosis of a pulmonary embolism: comparison of P792 and Gd-DOTA for first-pass perfusion MRI and contrast-enhanced 3D MRA in a rabbit model.
    Keilholz SD; Bozlar U; Fujiwara N; Mata JF; Berr SS; Corot C; Hagspiel KD
    Korean J Radiol; 2009; 10(5):447-54. PubMed ID: 19721829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic Contrast-Enhanced MRI Using a Macromolecular MR Contrast Agent (P792): Evaluation of Antivascular Drug Effect in a Rabbit VX2 Liver Tumor Model.
    Park HS; Han JK; Lee JM; Kim YI; Woo S; Yoon JH; Choi JY; Choi BI
    Korean J Radiol; 2015; 16(5):1029-37. PubMed ID: 26357497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal functional contrast-enhanced magnetic resonance imaging: evaluation of a new rapid-clearance blood pool agent (p792) in sprague-dawley rats.
    Mandry D; Pedersen M; Odille F; Robert P; Corot C; Felblinger J; Grenier N; Claudon M
    Invest Radiol; 2005 May; 40(5):295-305. PubMed ID: 15829826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary magnetic resonance angiography: experimental evaluation of the new rapid clearance blood pool contrast medium P792.
    Taupitz M; Schnorr J; Wagner S; Kivelitz D; Rogalla P; Claassen G; Dewey M; Robert P; Corot C; Hamm B
    Magn Reson Med; 2001 Nov; 46(5):932-8. PubMed ID: 11675645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity.
    Port M; Corot C; Violas X; Robert P; Raynal I; Gagneur G
    Invest Radiol; 2005 Sep; 40(9):565-73. PubMed ID: 16118549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved evaluation of myocardial perfusion and viability with the magnetic resonance blood pool contrast agent p792 in a nonreperfused porcine infarction model.
    Peukert D; Kaufels N; Laule M; Schnorr J; Carme S; Farr T; Schönenberger E; Taupitz M; Hamm B; Dewey M
    Invest Radiol; 2007 Apr; 42(4):248-55. PubMed ID: 17351432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative dynamic contrast enhanced MRI of experimental synovitis in the rabbit knee: comparison of macromolecular blood pool agents vs. Gadolinium-DOTA.
    Watrin-Pinzano A; Loeuille D; Goebel JC; Lapicque F; Walter F; Robert P; Netter P; Corot C; Gillet P; Blum A
    Biomed Mater Eng; 2008; 18(4-5):261-72. PubMed ID: 19065032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extremely Small Pseudoparamagnetic Iron Oxide Nanoparticle as a Novel Blood Pool T1 Magnetic Resonance Contrast Agent for 3 T Whole-Heart Coronary Angiography in Canines: Comparison With Gadoterate Meglumine.
    Park EA; Lee W; So YH; Lee YS; Jeon BS; Choi KS; Kim EG; Myeong WJ
    Invest Radiol; 2017 Feb; 52(2):128-133. PubMed ID: 27977466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved vessel delineation in keyhole time-resolved contrast-enhanced MR angiography using a gadolinium doped flush.
    Beranek-Chiu J; Froehlich JM; Wentz KU; Doert AN; Zollikofer CL; Eckhardt BP
    J Magn Reson Imaging; 2009 May; 29(5):1147-53. PubMed ID: 19388120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of true-FISP sequence added to conventional gadolinium-enhanced MRA of abdominal aorta and its major branches.
    Iozzelli A; D'Orta G; Aliprandi A; Secchi F; Di Leo G; Sardanelli F
    Eur J Radiol; 2009 Dec; 72(3):489-93. PubMed ID: 18926654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional multiphase time-resolved low-dose contrast-enhanced magnetic resonance angiography using TWIST on a 32-channel coil at 3 T: a quantitative and qualitative comparison of a conventional gadolinium chelate with a high-relaxivity agent.
    Giesel FL; Runge V; Kirchin M; Mehndiratta A; Gerigk L; Corell B; von Gall C; Kauczor HU; Essig M
    J Comput Assist Tomogr; 2010; 34(5):678-83. PubMed ID: 20861769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crossover comparison of ferumoxytol and gadobenate dimeglumine for abdominal MR-angiography at 3.0 tesla: Effects of contrast bolus length and flip angle.
    Schubert T; Motosugi U; Kinner S; Colgan TJ; Sharma SD; Hetzel S; Wells S; Campo CA; Reeder SB
    J Magn Reson Imaging; 2017 Jun; 45(6):1617-1626. PubMed ID: 27862577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-pass and equilibrium-MRA of the aortoiliac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot study.
    Tombach B; Reimer P; Bremer C; Allkemper T; Engelhardt M; Mahler M; Ebert W; Heindel W
    NMR Biomed; 2004 Nov; 17(7):500-6. PubMed ID: 15523717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced whole-heart coronary magnetic resonance angiography at 3.0 T: comparison with steady-state free precession technique at 1.5 T.
    Liu X; Bi X; Huang J; Jerecic R; Carr J; Li D
    Invest Radiol; 2008 Sep; 43(9):663-8. PubMed ID: 18708861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of field strengths on magnetic resonance angiography: comparison of an ultrasmall superparamagnetic iron oxide blood-pool contrast agent and gadopentetate dimeglumine in rabbits at 1.5 and 3.0 tesla.
    Allkemper T; Heindel W; Kooijman H; Ebert W; Tombach B
    Invest Radiol; 2006 Feb; 41(2):97-104. PubMed ID: 16428979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.